Four Reasons to Join the Mito Registry
Why you should join the Mito Registry, if you have been diagnosed with or are suspected to have mitochondrial disease (mito).
The Bloody Long Trek is Back!
Trek the Great Wall of China to cure mitochondrial disease (mito) – register now!
AussieMit 2018 Registrations Now Open!
Register now for Australia’s most important conference into mitochondrial research!
Mito Connect Call
16 June 2018
Adelaide Mito Information Day
23 June 2018
LHON Conference – Nashville
28 – 29 June 2018
FDA Grants NeuroVive’s KL1333 Orphan Drug Status for Treatment of Mitochondrial Diseases
Orphan Drug Designation of compound KL1333 is a positive step towards bringing such treatment to patients of inherited mitochondrial respiratory chain diseases in the US.
AMDF Position Statement: Use of Genetic Information by Life Insurers in Australia
In light of the recent Parliamentary Inquiry into the life insurance industry.
Stealth BioTherapeutics Granted Orphan Drug Designation of Elamipretide for Treatment of Leber’s Hereditary Optic Neuropathy
Orphan Drug Designation of investigational treatment for Leber’s hereditary optic neuropathy (LHON) is one step further to bringing such treatment to LHON patients in the US.